An observational study in Echinococcosis, Hepatic, sponsored by Trabzon Kanuni Education and Research Hospital. Status unknown at 1 site in Turkey. Open to participants aged 7 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-10-22.
Sponsored by Trabzon Kanuni Education and Research Hospital · Observational
Hypertonic saline (HS) is one of the most widely used scolocidal agents in the treatment of hydatid cysts. Hypernatremia is one of the complications associated with the use of HS. It can cause hypernatremia, acid-base disorder, impaired lung, renal, cardiac and neurological functions and even death. Therefore, caution should be exercised in the use of HS, and open technique should be preferred in surgery.
25 studies on the registry are indexed under Echinococcosis; 4 are open to participants now.
This study's planned enrollment of 30 is below the median of 45 across 18 observational studies indexed under Echinococcosis.
Browse Echinococcosis studies →Trabzon Kanuni Education and Research Hospital is the lead sponsor of 12 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients treated who hydatid cyst with hypertonic saline
Inclusion Criteria: Patients who developed hypernatremia (plasma sodium value above 145 mmol/L) due to HS use in the treatment of hydatid cyst were included to study -
Exclusion Criteria:Patients who developed hypernatremia due to other treatments were excluded from the study.
-
Hypernatremia (plasma sodium value above 145 mmol/L) due to HS use in the treatment of hydatid cyst.
Procedure: Treatment
Surgery and PAIR
Prevention of hypernatreima
Hypernatremia is plasma sodium value above 145 mmol/L.
Time frame: 3 month
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2021 (actual). Primary completion is estimated for Oct 2021, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Trabzon Kanuni Education and Research Hospital